Back

Role of Vericiguat on clinical, echocardiographic and comprehensive geriatric assessment parameters in elderly patients with worsening Heart Failure

18 May 2025 (12:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Updates in advanced and acute heart failure Multidisciplinary Interventions HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Giuseppe Armentaro

University Hospital Renato Dulbecco, Catanzaro (Italy)

4 More presentations in this session

Presentation thumbnail
Intravenous nitroglycerin improves decongestion in a propensity matched acute heart failure cohort.
Doctor M. Hoen (Heerlen, NL)
Abstract Slides Video
Presentation thumbnail
Acute heart failure patients with iron deficiency: does etiology really matter?
Doctor J. Ferraro (Penafiel, PT)
Abstract Slides Video
Presentation thumbnail
PRACTICE-HF : an implementation study of an updated acute heart failure protocol.
Mr L. Peeters (Heerlen, NL)
Abstract Slides Video
Presentation thumbnail
Hospital admissions and long-term outcomes in advanced heart failure patients with persistent congestion treated with sustained low-efficiency dialysis
Doctor T. Furlan (Trbovlje, SI)
Abstract Slides Video

Access the full session

Session thumbnail
Updates in advanced and acute heart failure

The Event

Event poster

Heart Failure 2025

18 May 2025 12:00 CET
You may be interested in
thumbnail
Congress Presentation
Initial experience of vericiguat treatment in patients with heart failure and high risk of decompensation.
thumbnail
Congress Presentation
A study to assess the role of vericiguat in the cardio-pulmonary pathophysiology in worsening heart failure with reduced ejection fraction (REVOLUT- HFrEF)
thumbnail
Congress Presentation
Vericiguat in a real-world heart failure population: a single-centre experience

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources